Cargando…

Current Therapy and Liver Transplantation for Portopulmonary Hypertension in Japan

Portopulmonary hypertension (PoPH) and hepatopulmonary syndrome are severe pulmonary complications associated with liver cirrhosis (LC) and portal hypertension. Three key pathways, involving endothelin, nitric oxide, and prostacyclin, have been identified in the development and progression of pulmon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tokushige, Katsutoshi, Kogiso, Tomomi, Egawa, Hiroto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867251/ https://www.ncbi.nlm.nih.gov/pubmed/36675490 http://dx.doi.org/10.3390/jcm12020562

Ejemplares similares

Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates
por: Hayashi, Ryoko, et al.
Publicado: (2022)

The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Elevated α-Fetoprotein in the Absence of Carcinoma Caused by Relapse of Hepatitis C Viral Infection after Liver Transplantation
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Fontan-associated liver disease and hepatocellular carcinoma in adults
por: Kogiso, Tomomi, et al.
Publicado: (2020)

Portopulmonary hypertension
por: Saleemi, Sarfraz
Publicado: (2010)

Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study
por: Kogiso, Tomomi, et al.
Publicado: (2017)

The early outcomes of candidates with portopulmonary hypertension after liver transplantation
por: Huang, Bingsong, et al.
Publicado: (2018)

Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients
por: Li, Jian, et al.
Publicado: (2018)

Portopulmonary Hypertension: An Updated Review
por: Jasso-Baltazar, Erick A., et al.
Publicado: (2023)

The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan
por: Takahashi, Yukiko, et al.
Publicado: (2021)

Hepatocellular carcinoma after direct‐acting antiviral drug treatment in patients with hepatitis C virus
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Giant Hepatic Hemangioma Causing Prolonged Fever and Indicated for Resection
por: Yoshimizu, Chihiro, et al.
Publicado: (2021)

Venous outflow obstruction and portopulmonary hypertension after orthotopic liver transplantation
por: Aguirre-Avalos, Guadalupe, et al.
Publicado: (2013)

Living donor liver transplantation in a patient with severe portopulmonary hypertension
por: Singh, Shweta A, et al.
Publicado: (2020)

Differences in the genetic backgrounds of patients with alcoholic liver disease and non‐alcoholic fatty liver disease
por: Yamamoto, Kuniko, et al.
Publicado: (2018)

Liver transplantation for severe portopulmonary hypertension: A case report and literature review
por: Chen, Xiao-Jie, et al.
Publicado: (2019)

Current clinical understanding and effectiveness of portopulmonary hypertension treatment
por: Tamura, Yuichi, et al.
Publicado: (2023)

Outcomes of fatty liver disease with and without metabolic comorbidities and risk factors for mortality
por: Ogasawara, Yuri, et al.
Publicado: (2023)

Analysis of genetic factors associated with fatty liver disease‐related hepatocellular carcinoma
por: Kogiso, Tomomi, et al.
Publicado: (2023)

The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease
por: Chishima, Sayaka, et al.
Publicado: (2017)

Role of echocardiography in screening for portopulmonary hypertension in liver transplant candidates: a meta-analysis
por: Yin, Xin, et al.
Publicado: (2020)

Long‐term outcome of Wilson's disease complicated by liver disease
por: Arai, Satoko, et al.
Publicado: (2021)

Treatment pattern and clinical outcomes in portopulmonary hypertension: A database study in Japan
por: Atsukawa, Masanori, et al.
Publicado: (2022)

Portopulmonary Hypertension: From Bench to Bedside
por: Thomas, Christopher, et al.
Publicado: (2020)

Causes and Circumstances of Death in Portopulmonary Hypertension
por: Sahay, Sandeep, et al.
Publicado: (2021)

Current Status of ABO-incompatible Liver Transplantation
por: Egawa, Hiroto, et al.
Publicado: (2022)

Portopulmonary hypertension: Success with combined medical treatment
por: Hernández, María, et al.
Publicado: (2023)

Impact of continued administration of tolvaptan on cirrhotic patients with ascites
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Long-term Follow-up of a Patient with Portal Hypertension and Hepatic Failure Due to Hepatic Hydatid Disease
por: Takenaka, Yuki, et al.
Publicado: (2021)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Portopulmonary hypertension
por: Saleemi, Sarfraz, et al.
Publicado: (2014)

Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm Hg
por: DuBrock, Hilary M., et al.
Publicado: (2020)

Management of acute subdural hematoma in a patient with portopulmonary hypertension on prostanoid therapy
por: Rammo, Richard, et al.
Publicado: (2017)

Symptom‐based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease
por: Wakabayashi, Shun‐Ichi, et al.
Publicado: (2023)

Temporal Trends in Portopulmonary Hypertension Model for End-stage Liver Disease Exceptions and Outcomes
por: del Valle, Kathryn T., et al.
Publicado: (2022)

Portopulmonary hypertension caused by portal hypertension that is complicated by central diabetes insipidus
por: Zhao, Tingting, et al.
Publicado: (2020)

BMP9 Morphs into a Potential Player in Portopulmonary Hypertension
por: Toshner, Mark
Publicado: (2019)

Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes
por: DuBrock, Hilary M., et al.
Publicado: (2019)

Possible use of pulmonary artery stiffness in screening for portopulmonary hypertension
por: Wessels, Jeroen N., et al.
Publicado: (2022)

Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis
por: Krowka, Michael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ogba95h4a4r5aoiupj2pot4aqr